Shuttle Pharmaceuticals Holdings, Inc. announced that it has entered into a securities purchase agreement with new investor, SRO, LLC to issue units for the gross proceeds of $2,250,000 on February 7, 2024. Each unit consists of one share of SHPH common stock and a warrant to purchase one share of SHPH common stock exercisable at a purchase price of $2.35 per share. The Units will be sold at a per Unit price equal to 90% of the VWAP of SHPH common stock for the five trading days immediately preceding closing.